Table 3.
Activities of antioxidant enzymes (mean value ± standard deviation (SD)) in healthy subjects before and after the completion of a cycle of ten whole-body cryotherapy procedures with subsequent kinesiotherapy (WBC group) or a cycle of ten kinesiotherapy procedures only (KT group), with statistical analyses.
| Parameters | WBC group | KT group | P | |
|---|---|---|---|---|
| Total SOD (p) (NU/ml) |
Before | 9.43 ± 2.77 | 11.2 ± 1.93 | 0.050 |
| After | 9.40 ± 3.07 | 11.6 ± 3.26 | 0.062 | |
| P ∗ | 0.818 | 0.679 | ||
| Δ | −0.03 ± 4.74 | 0.40 ± 3.82 | 0.775 | |
|
| ||||
| SOD-Mn (p) (NU/ml) |
Before | 3.96 ± 2.01 | 4.50 ± 1.41 | 0.387 |
| After | 5.19 ± 2.05 | 5.16 ± 2.19 | 0.964 | |
| P ∗ | 0.030 | 0.179 | ||
| Δ | 1.23 ± 1.96 | 0.65 ± 2.00 | 0.419 | |
|
| ||||
| SOD-CuZn (p) (NU/ml) |
Before | 6.77 ± 2.70 | 6.72 ± 1.96 | 0.957 |
| After | 4.84 ± 2.05 | 6.60 ± 2.92 | 0.060 | |
| P ∗ | 0.063 | 0.918 | ||
| Δ | −1.93 ± 4.05 | −0.12 ± 3.05 | 0.166 | |
|
| ||||
| Total SOD (e) (NU/mgHb) |
Before | 83.0 ± 9.82 | 114.0 ± 20.8 | <0.001 |
| After | 102.0 ± 13.1 | 98.5 ± 17.4 | 0.493 | |
| P ∗ | 0.001 | 0.002 | ||
| Δ | 19.3 ± 13.9 | −15.3 ± 12.7 | <0.001 | |
|
| ||||
| CAT (e) (IU/mgHb) |
Before | 104.0 ± 15.0 | 128.0 ± 11.2 | 0.352 |
| After | 112.0 ± 11.2 | 111.0 ± 15.6 | 0.242 | |
| P ∗ | 0.179 | 0.049 | ||
| Δ | 34.4 ± 87.0 | 39.9 ± 80.0 | 0.853 | |
|
| ||||
| GPx (e) (IU/gHb) |
Before | 23.1 ± 3.86 | 23.8 ± 7.20 | 0.752 |
| After | 22.0 ± 4.57 | 21.2 ± 3.71 | 0.606 | |
| P ∗ | 0.121 | 0.179 | ||
| Δ | −1.17 ± 3.31 | −2.59 ± 7.99 | 0.519 | |
|
| ||||
| GR (e) (IU/gHb) |
Before | 1.17 ± 0.37 | 1.49 ± 0.53 | 0.056 |
| After | 0.99 ± 0.48 | 1.14 ± 0.61 | 0.450 | |
| P ∗ | 0.134 | 0.010 | ||
| Δ | −0.18 ± 0.43 | −0.35 ± 0.44 | 0.267 | |
P: statistical significance of differences between both groups of patients; P∗: statistical significance of differences between values before and after treatment in particular groups of subjects. (p): plasma; (e): erythrocyte lysates; Δ: difference prior to posttreatment.